Personalized Medicine in Emerging Markets

 

With the arrival of powerful but high-priced personalized medicines, we must understand the role that these innovative new therapies will play in emerging markets. This panel will discuss the pathways, challenges, and opportunities to making personalized medicine accessible in emerging markets.

 
 
Kris Olson.png

Kris Olson

Director, MGH Springboards Studio

 
Anjali Sastry Photo.png

Anjali Sastry

Senior lecturer, system dynamics, mit sloan

Ian+Woo.jpg

Ian Woo

CFO, Everest Medicines

Vik Bakhru.jpg
Karla Unger Photo.jpg

Karla Unger

Research Professor, National Cancer Institute (Mexico)

Moderator: Vik Bakhru

COO, ConsejoSano